Sanara Medtech Inc expected to post a loss of 13 cents a share - Earnings Preview

Sanara MedTech

22/03/2024 20:28

* Sanara Medtech Inc  SMTI.OQ   SMTI.O  is expected to show
a rise
in quarterly revenue when it reports  results on March 25 for
the period ending December 31 2023
    * The Fort Worth Texas-based  company is expected to report
a
7.7% increase in revenue to $16.5 million from $15.32 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Sanara Medtech Inc is
for a
loss of 13 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for
the pharmaceuticals
peer group is also "Buy".​
    * Wall Street's median 12-month price target for Sanara
Medtech
Inc is $49.00​, above​ its last closing price of $37.72. ​​​

This summary was machine generated March 22 at 20:28 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)